Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

Market Cap	7.91B +5.4%
Revenue (ttm)	1.24B +9.4%
Net Income	301.80M +5.9%
EPS	0.52 +16.8%
Shares Out	543.47M
PE Ratio	28.00
Forward PE	25.53
Dividend	0.11 (0.76%)
Ex-Dividend Date	Apr 30, 2025

Volume	16,253,400
Average Volume	23,785,961
Open	16.60
Previous Close	14.95
Day's Range	14.41 - 16.60
52-Week Range	11.58 - 19.67
Beta	0.47
RSI	35.58
Earnings Date	Apr 18, 2026

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lano...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 1,021
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300401

Financial Performance

In 2024, SHE:300401's revenue was 1.24 billion, an increase of 13.58% compared to the previous year's 1.09 billion. Earnings were 309.21 million, an increase of 60.76%.